SRL
AXSM icon

Scientech Research LLC’s Axsome Therapeutics AXSM Stock Holding History

Scientech Research LLC’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$201K Buy
+820
New +$178K 0.16% 163
2026
Q1 		– Sell
-3,593
Closed -$656K – 482
2025
Q4 		$656K Buy
+3,593
New +$502K 0.41% 53
2025
Q2 		– Sell
-9,759
Closed -$1.14M – 597
2025
Q1 		$1.14M Buy
+9,759
New +$1.11M 0.3% 62

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Scientech Research LLC's AXSM Position: Q2 2026 in Review

Scientech Research LLC opened a new position in Axsome Therapeutics (AXSM) in Q2 2026: 820 shares worth $201K. The stake represents 0.16% of the portfolio and ranks #163 among its holdings. This is a return to the name: Scientech Research LLC previously reported a position in AXSM as recently as Q4 2025.

Scientech Research LLC first reported a position in AXSM in Q1 2025 and has held it in 3 quarters since. The position peaked at $1.14M in Q1 2025. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Scientech Research LLC held 820 shares of Axsome Therapeutics worth $201K as of Q2 2026.
  • Axsome Therapeutics was a new Scientech Research LLC position in Q2 2026.
  • Axsome Therapeutics made up 0.16% of Scientech Research LLC's portfolio in Q2 2026, its #163 holding.
  • Scientech Research LLC first reported a position in Axsome Therapeutics in Q1 2025 and has held it in 3 quarters since.
  • Scientech Research LLC's Axsome Therapeutics position peaked at $1.14M in Q1 2025.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Scientech Research LLC's 13F filing for Q2 2026, filed 14 Aug 2026.